<h3>享受 TipRanks Premium 50% 折扣</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>通過最新的新聞和分析保持市場領先，最大化您的投資組合潛力</li>
</ul>
<p>CLSA Premium Ltd. ( (HK:6877) ) 提供了最新動態。</p>
<p>Top Eminent Healthcare Group Limited 已同意以 1.003 億港元收購 Top Eminent II Limited 的 100% 股權，此交易被歸類為香港上市規則下的重大關聯交易。目標集團控制着通過結構性合同從事互聯網醫療和在線醫療服務的中國大陸實體，使 Top Eminent Healthcare 能夠整合其財務結果並充分捕捉其經濟利益。</p>
<p>由於賣方是公司控股股東的全資子公司，該交易被視為關聯交易，需要獨立股東批准，並遵守報告、審查和通函要求。已成立獨立董事委員會，並任命 Ignite Capital (Asia Pacific) Limited 為獨立財務顧問，詳細説明收購和合同安排的通函將在特別股東大會之前發送給股東。</p>
<p>關於 (HK:6877) 股票的最新分析師評級為持有，目標價格為 0.15 港元。要查看 CLSA Premium Ltd. 股票的完整分析師預測列表，請參見 HK:6877 股票預測頁面。</p>
<p><strong>關於 CLSA Premium Ltd. 的更多信息</strong></p>
<p>Top Eminent Healthcare Group Limited 是一家在開曼羣島註冊的公司，上市於香港，經營醫療保健行業。通過其在中國大陸的子公司和合同安排，該集團專注於互聯網醫療、互聯網醫院服務、在線醫療諮詢及相關增值健康管理服務，目標市場為外資在該領域受限的中國市場。</p>
<p><strong>平均交易量：</strong> 491,078</p>
<p><strong>技術情緒信號：</strong> 賣出</p>
<p><strong>當前市值：</strong> 3.009 億港元</p>
<p>在 TipRanks 的股票分析頁面瞭解更多關於 6877 股票的信息。</p>

廣發中證香港創新藥(QDII-ETF)

06877

<p>頂尖卓越醫療集團有限公司將以 1 億港元收購頂尖卓越二有限公司 100% 的股份，此交易屬於香港上市規則下的關聯交易。此次收購使頂尖卓越能夠整合來自中國大陸互聯網醫療實體的財務業績。由於賣方是控股股東的子公司，因此需要獨立股東的批准。已成立獨立董事會委員會，Ignite Capital (Asia Pacific) Limited 將擔任獨立財務顧問。CLSA Premium Ltd.（港股代碼：6877）的最新分析師評級為持有，目標價格為 0.15 港元</p>

<h3>Claim 50% Off TipRanks Premium</h3>
<div class="lb-trans"><h3>享受 TipRanks Premium 50% 折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>通過最新的新聞和分析保持市場領先，最大化您的投資組合潛力</li>
</ul>
</div><p>CLSA Premium Ltd. ( (HK:6877) ) has provided an update.</p>
<div class="lb-trans"><p>CLSA Premium Ltd. ( (HK:6877) ) 提供了最新動態。</p>
</div><p>Top Eminent Healthcare Group Limited has agreed to acquire 100% of Top Eminent II Limited for HK$100.3 million, in a deal classified as both a major and connected transaction under Hong Kong listing rules. The target group controls PRC entities engaged in internet-based healthcare and online medical services via structured contracts, enabling Top Eminent Healthcare to consolidate their financial results and fully capture their economic benefits.</p>
<div class="lb-trans"><p>Top Eminent Healthcare Group Limited 已同意以 1.003 億港元收購 Top Eminent II Limited 的 100% 股權，此交易被歸類為香港上市規則下的重大關聯交易。目標集團控制着通過結構性合同從事互聯網醫療和在線醫療服務的中國大陸實體，使 Top Eminent Healthcare 能夠整合其財務結果並充分捕捉其經濟利益。</p>
</div><p>Because the vendor is a wholly owned subsidiary of the company’s controlling shareholder, the transaction is treated as a connected deal that requires independent shareholder approval and compliance with reporting, review and circular requirements. An Independent Board Committee has been formed and Ignite Capital (Asia Pacific) Limited appointed as independent financial adviser, with a circular detailing the acquisition and contractual arrangements to be sent to shareholders ahead of an extraordinary general meeting.</p>
<div class="lb-trans"><p>由於賣方是公司控股股東的全資子公司，該交易被視為關聯交易，需要獨立股東批准，並遵守報告、審查和通函要求。已成立獨立董事委員會，並任命 Ignite Capital (Asia Pacific) Limited 為獨立財務顧問，詳細説明收購和合同安排的通函將在特別股東大會之前發送給股東。</p>
</div><p>The most recent analyst rating on (HK:6877) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on CLSA Premium Ltd. stock, see the HK:6877 Stock Forecast page.</p>
<div class="lb-trans"><p>關於 (HK:6877) 股票的最新分析師評級為持有，目標價格為 0.15 港元。要查看 CLSA Premium Ltd. 股票的完整分析師預測列表，請參見 HK:6877 股票預測頁面。</p>
</div><p><strong>More about CLSA Premium Ltd.</strong></p>
<div class="lb-trans"><p><strong>關於 CLSA Premium Ltd. 的更多信息</strong></p>
</div><p>Top Eminent Healthcare Group Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the healthcare sector. Through its subsidiaries and contractual arrangements in mainland China, the group focuses on internet-based healthcare, internet hospital services, online medical consultation and related value-added health management services aimed at the PRC market, where foreign ownership is restricted in this segment.</p>
<div class="lb-trans"><p>Top Eminent Healthcare Group Limited 是一家在開曼羣島註冊的公司，上市於香港，經營醫療保健行業。通過其在中國大陸的子公司和合同安排，該集團專注於互聯網醫療、互聯網醫院服務、在線醫療諮詢及相關增值健康管理服務，目標市場為外資在該領域受限的中國市場。</p>
</div><p><strong>Average Trading Volume:</strong> 491,078</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 491,078</p>
</div><p><strong>Technical Sentiment Signal:</strong> Sell</p>
<div class="lb-trans"><p><strong>技術情緒信號：</strong> 賣出</p>
</div><p><strong>Current Market Cap:</strong> HK$300.9M</p>
<div class="lb-trans"><p><strong>當前市值：</strong> 3.009 億港元</p>
</div><p>Learn more about 6877 stock on TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>在 TipRanks 的股票分析頁面瞭解更多關於 6877 股票的信息。</p>
</div>

頂尖卓越醫療以 1.003 億港元收購在線醫療平台的關聯交易